In the Netherlands, three million CT and MRI scans are made annually. These scans can reveal cancer at an early stage when treatment is most effective. LesionLens is an innovative AI startup that identifies potential abnormalities in these scans and estimates the malignancy risk in each suspicious region using advanced 3D deep learning techniques. Our technology is proven effective for detecting lung cancer in CT scans and prostate cancer in MRI scans. We are actively partnering with various radiology departments to broaden our application range, ensuring radiologists have consistent support and making early and precise cancer detection more accessible.